Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04602078
Title Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma (AUREA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Atezolizumab + Cisplatin + Gemcitabine

Age Groups: senior | adult
Covered Countries


No variant requirements are available.